Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults (The Harmony Study)

NCT04856865 is registered in ClinicalTrials.gov with Alladapt Immunotherapeutics, Inc. as lead sponsor.

NCT NCT04856865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04856865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults (The Harmony Study)
Lead sponsor
Alladapt Immunotherapeutics, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
April 20, 2021
Completion date
December 13, 2022
Enrollment
73 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

food allergy